AGE/GENDER EFFECTS ON SAFETY, TOLERANCE, AND PHARMACOKINETICS OF BAY X3702

年龄/性别对 BAY X3702 的安全性、耐受性和药代动力学的影响

• 批准号: 5218619
• 负责人: LAWRENCE L FLECKENSTEIN
• 金额: --
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/5218619
• 关键词: age difference; brain disorder chemotherapy; cardiovascular disorder chemotherapy; cardiovascular pharmacology; clinical research; clinical trials; drug screening /evaluation; gender difference; human old age (65+); human subject; neurotransmitter agonist; pharmacokinetics; serotonin receptor; stroke

Evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BAY x3702 in healthy elderly subjects for possible future use in treating stroke.

评价安全性、耐受性、药代动力学和药效学 BAY x3702在健康老年受试者中的应用，未来可能用于 治疗中风